The diagnosis and management of pre-invasive breast disease Genetic alterations in pre-invasive lesions
Open Access
- 9 October 2003
- journal article
- review article
- Published by Springer Nature in Breast Cancer Research
- Vol. 5 (6) , 313-319
- https://doi.org/10.1186/bcr650
Abstract
The development of modern molecular genetic techniques has allowed breast cancer researchers to clarify the multistep model of breast carcinogenesis. Laser capture microdissection coupled with comparative genomic hybridisation and/or loss-of-heterozygosity methods have confirmed that many pre-invasive lesions of the breast harbour chromosomal abnormalities at loci known to be altered in invasive breast carcinomas. Current data do not provide strong evidence for ductal hyperplasia of usual type as a precursor lesion, although some are monoclonal proliferations; however, atypical hyperplasia and in situ carcinoma appear to be nonobligate precursors. We review current knowledge and the contribution of molecular genetics in the understanding of breast cancer precursors and pre-invasive lesions.Keywords
This publication has 64 references indexed in Scilit:
- The role of E‐cadherin in low‐grade ductal breast tumourigenesisThe Journal of Pathology, 2003
- Clinical, Histopathologic, and Biologic Features of Pleomorphic Lobular (Ductal-Lobular) Carcinoma In Situ of the Breast: A Report of 24 CasesLaboratory Investigation, 2002
- Microsatellite analysis of breast carcinoma and corresponding local recurrencesThe Journal of Pathology, 2002
- Genetic pathways in the evolution of breast ductal carcinoma in situThe Journal of Pathology, 2002
- Allelic imbalance analysis of chromosome 16q shows that grade I and grade III invasive ductal breast cancers follow different genetic pathwaysThe Journal of Pathology, 2001
- Solid Low-Grade In Situ Carcinoma of the BreastThe American Journal of Surgical Pathology, 2001
- Loss of Heterozygosity in Normal Tissue Adjacent to Breast CarcinomasScience, 1996
- Characterization of Extensive Genetic Alterations in Ductal Carcinoma In Situ by Fluorescence In Situ Hybridization and Molecular AnalysisJNCI Journal of the National Cancer Institute, 1995
- Consistency of histopathological reporting of breast lesions detected by screening: Findings of the U.K. National External Quality Assessment (EQA) schemeEuropean Journal Of Cancer, 1994
- Immunohistochemical distribution of c‐erbB‐2 in infiltrating and in situ breast cancerInternational Journal of Cancer, 1988